1 Fawcett EJ, Power H, Fawcett JM. Women are at greater risk of OCD than men: a meta-analytic review of OCD prevalence worldwide. J Clin Psychiatry. 2020;81(4):19r13085.
2 American Psychiatric Association, Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. 2013, Arlington, VA: American Psychiatric Association.
3 Ruscio AM, et al. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry. 2010; 15(1):53–63.
4 Pauls DL. The genetics of obsessive-compulsive disorder: a review. Dialogues Clin Neurosci. 2010;12(2):149–63.
5 Escobar AP, et al. The neuronal glutamate transporter EAAT3 in obsessive-compulsive disorder. Front Pharmacol. 2019; 10:1362.
6 Zuchner S, et al. Multiple rare SAPAP3 missense variants in trichotillomania and OCD. Mol Psychiatry. 2009;14(1):6–9.
7 Kim E, Sheng M. PDZ domain proteins of synapses. Nat Rev Neurosci. 2004;5(10):771–81.
8 Chen M, et al. Sapap3 deletion anomalously activates short-term endocannabinoid-mediated synaptic plasticity. J Neurosci. 2011;31(26):9563–73.
9 Pauls DL, et al. Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective. Nat Rev Neurosci. 2014; 15(6):410–24.
10 Welch JM, et al. Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature. 2007;448(7156):894–900.
11 Hadjas LC, et al. Projection-specific deficits in synaptic transmission in adult Sapap3-knockout mice. Neuropsychopharmacology. 2020;45(12):2020–9.
12 Mallet L, et al. Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med. 2008;359(20):2121–34.
13 Ly C, et al. Psychedelics promote structural and functional neural plasticity. Cell Rep. 2018;23(11):3170–82.